AJP - GI  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (April 9, 2009). doi:10.1152/ajpgi.90508.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/6/G1230    most recent
90508.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hazelgrove, K. B.
Right arrow Articles by Kuemmerle, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hazelgrove, K. B.
Right arrow Articles by Kuemmerle, J. F.
Submitted on August 20, 2008
Revised on March 31, 2009
Accepted on March 31, 2009

Endogenous IGF-I and {alpha}V{beta}3 Integrin Ligands Regulate Increased Smooth Muscle Growth in TNBS-induced Colitis

Krystina B. Hazelgrove, Robert S Flynn1, Li-Ya Qiao1, John R Grider1, and John F. Kuemmerle2*

1 Virginia Commonwealth University
2 Med Col Virginia, VCU

* To whom correspondence should be addressed. E-mail: jkuemmerle{at}hsc.vcu.edu.

Endogenous Insulin-like growth factor-I (IGF-I) regulates intestinal smooth muscle growth by concomitantly stimulating proliferation and inhibiting apoptosis. IGF-I-stimulated growth is augmented by the {alpha}V{beta}3 integrin ligands, vitronectin and fibronectin. IGF-I expression in smooth muscle is increased in both TNBS-induced colitis and Crohn's Disease. We hypothesized that intestinal inflammation increased vitronectin and fibronectin expression by smooth muscle and, along with IGF-I upregulation, increased intestinal muscle growth. Intestinal smooth muscle cells were examined seven days following the induction of TNBS-induced colitis. While {alpha}V{beta}3 integrin expression was not altered by TNBS-induced colitis, vitronectin and fibronectin levels were increased by 80 ± 10% and 90 ± 15% above control levels. Basal IGF-I receptor phosphorylation in inflamed muscle from TNBS-treated rats was increased by 86 ± 8% over vehicle-treated controls. Basal Erk1/2, p70S6 kinase and GSK-3{beta} phosphorylation in muscle cells of TNBS- treated rats were also increased by 140-180%. TNBS-treatment increased basal muscle cell proliferation by 130 ± 15% and decreased apoptosis by 20 ± 2% compared to that in vehicle-treated controls. The changes in proliferation and apoptosis were reversed by an IGF-I receptor tyrosine kinase inhibitor or an {alpha}V{beta}3 integrin antagonist. The results suggest that smooth muscle hyperplasia in TNBS-induced colitis partly results from the upregulation of endogenous IGF-I and ligands of {alpha}V{beta}3 integrin that mediate increased smooth muscle cell proliferation and decreased apoptosis. This paper has identified one mechanism regulating smooth muscle hyperplasia, a feature of stricture formation that occurs in the chronically inflamed intestine of TNBS-induced colitis and potentially Crohn's disease.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.